News

Season's greetings from Fermion president Arto Toivonen

Fermion scales up it's OEB5 micronization capabilities

Orion as a long term partner for production of hormonal gels – customer view

How to succeed in technology transfers for hormonal gels – 4 critical factors

Fermion increases manufacturing capacity for highly potent APIs at its Hanko site

Fermion has received fluticasone propionate CEP Fermion has received fluticasone propionate CEP

Green chemistry strengthens Orion's environmental responsibility Green chemistry strengthens Orion's environmental responsibility

Fermion's mother company Orion Corporation wins CMO leadership awards in the category of expertise Fermion's mother company Orion Corporation wins CMO leadership awards in the category of expertise

Fermion's long term customer G1 Therapeutics received FDA approval for COSELA™ (Trilaciclib) Fermion's long term customer G1 Therapeutics received FDA approval for COSELA™ (Trilaciclib)

Orion uses waste ethanol to reduce the nitrogen load in the Baltic Sea Orion uses waste ethanol to reduce the nitrogen load in the Baltic Sea